OneAscent Financial Services LLC Buys Shares of 6,365 CVS Health Corporation $CVS

OneAscent Financial Services LLC purchased a new position in shares of CVS Health Corporation (NYSE:CVS) during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 6,365 shares of the pharmacy operator’s stock, valued at approximately $658,000.

A number of other hedge funds and other institutional investors have also modified their holdings of the business. Kilter Group LLC bought a new stake in CVS Health in the second quarter worth $27,000. Beaird Harris Wealth Management LLC increased its position in CVS Health by 201.0% during the second quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator’s stock worth $30,000 after buying an additional 195 shares during the last quarter. J.Safra Asset Management Corp bought a new position in CVS Health during the second quarter valued at about $30,000. Dunhill Financial LLC acquired a new stake in shares of CVS Health in the second quarter worth about $32,000. Finally, Swiss RE Ltd. bought a new stake in shares of CVS Health during the 4th quarter worth about $26,000. Institutional investors own 80.66% of the company’s stock.

Analyst Upgrades and Downgrades

CVS has been the topic of a number of recent analyst reports. Truist Financial raised their price objective on CVS Health from $108.00 to $118.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. Sanford C. Bernstein upped their target price on CVS Health from $94.00 to $106.00 and gave the stock an “outperform” rating in a research report on Tuesday, May 12th. HSBC reiterated a “hold” rating and set a $103.00 price target on shares of CVS Health in a report on Monday, July 6th. Mizuho boosted their price objective on shares of CVS Health from $110.00 to $115.00 and gave the stock an “outperform” rating in a research note on Monday, June 8th. Finally, Wells Fargo & Company upped their price objective on shares of CVS Health from $103.00 to $123.00 and gave the stock an “overweight” rating in a report on Monday, July 13th. Twenty-two equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $107.17.

CVS Health Stock Up 0.2%

CVS stock opened at $93.83 on Friday. CVS Health Corporation has a twelve month low of $69.51 and a twelve month high of $110.68. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.74. The company has a market cap of $120.01 billion, a PE ratio of 24.82, a price-to-earnings-growth ratio of 0.89 and a beta of 0.61. The business’s 50-day simple moving average is $102.19 and its 200 day simple moving average is $88.83.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 EPS for the quarter, topping analysts’ consensus estimates of $1.87 by $0.71. The company had revenue of $106.10 billion during the quarter, compared to the consensus estimate of $100.03 billion. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The company’s quarterly revenue was up 7.3% on a year-over-year basis. During the same quarter last year, the company earned $1.81 EPS. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. On average, research analysts anticipate that CVS Health Corporation will post 8.02 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, August 3rd. Shareholders of record on Thursday, July 23rd were paid a dividend of $0.665 per share. The ex-dividend date was Thursday, July 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 2.8%. CVS Health’s payout ratio is currently 70.37%.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.